Projects per year
Personal profile
Research interests
To understand how neuroinflammation can lead to neurological diseases.
Research Overview
Our research goals are to understand the neuroinflammatory and neuroimmunological processes in a number of neurological conditions. Our research is transitional in nature involving bed (hospital) to bench (laboratory) neuroscience approaches. The key disease states that we focus on are Multiple Sclerosis, Autoimmune Encephalitis, Human Gliomas, Stroke related neuroinflammation, and traumatic brain injury and neuroinflammatory cascades.
Education/Academic qualification
Neurology, Neurology Specialist Qualification - FRACP, Royal Australasian College of Physicians
Neuroimmunology , Fellowship , Royal Melbourne Hospital
Physician Training , Fellow of the Australian College of Physicians , FRACP Australiasian College of Physicians
Bachelor of Medicine, Bachelor of Surgery , Bachelor of Medicine, Bachelor of Surgery , University of Melbourne
Neuroscience, Neuroimmunology, PhD , University of Melbourne
Neuroscience , Bachelor of Science Honours , University of Melbourne
Biomedicine , Bachelor of Biomedicine
Research area keywords
- neurology
- neuroimmunology
- neuroinflammation
- Multiple Sclerosis (MS)
- Autoimmune Encephalitis
- Gliomas
- Microglia
- Purinergic receptors
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2018 2022
CLADIN sub study. Effect of CLADribine on Innate Immune Response (CLADIN). MS Immunity Project.
Monif, M., Butzkueven, H. & O'Brien, T.
27/06/19 → 9/09/22
Project: Research
The role of microglia and P2X7 Receptor in human gliomas – a translational study
Monif, M., Drummond, K., O'Brien, T., Williams, D. & Kan, K.
1/01/19 → 31/12/19
Project: Research
PhD Project: Altered Vitamin D responsiveness in Multiple Sclerosis Immune Cells.
Butzkueven, H., Van Der Walt, A., Stankovich, J., Jokubaitis, V. & Monif, M.
16/10/18 → 1/01/20
Project: Research
The therapeutic role of P2X7 Receptor antagonism in human brain tumours
1/01/20 → 2/02/21
Project: Research
Research Output 2004 2019
Case reports of unexplained weight loss in autoimmune central neurological syndromes with anti-GAD antibodies
Broadley, J. & Monif, M., 24 Jan 2019, In : Case reports in internal medicine . 6, 2, p. 1-6 6 p.Research output: Contribution to journal › Article › Other › peer-review
Innate Immunity in the Central Nervous System: A Missing Piece of the Autoimmune Encephalitis Puzzle?
Wesselingh, R., Butzkueven, H., Buzzard, K., Tarlinton, D., O'Brien, T. J. & Monif, M., 1 Jan 2019, In : Frontiers in Immunology. 10, 14 p., 2066.Research output: Contribution to journal › Review Article › Research › peer-review
Open Access
File
6
Citations
(Scopus)
Prognosticating autoimmune encephalitis: A systematic review
Broadley, J., Seneviratne, U., Beech, P., Buzzard, K., Butzkueven, H., O'Brien, T. & Monif, M., 1 Jan 2019, In : Journal of Autoimmunity. 96, p. 24-34 11 p.Research output: Contribution to journal › Review Article › Research › peer-review
Status Epilepticus Complicating Anti-Ma2 Antibody Associated Paraneoplastic Autoimmune Encephalitis
Wesselingh, R. & Monif, M., 15 Feb 2019, In : Neurological Disorders and Epilepsy Journal . 2, 1, 5 p., 121.Research output: Contribution to journal › Article › Other › peer-review
Open Access
1
Citation
(Scopus)
The role of microglia and P2X7 receptors in gliomas
Kan, L. K., Williams, D., Drummond, K., O'Brien, T. & Monif, M., 15 Jul 2019, In : Journal of Neuroimmunology. 332, p. 138-146 9 p.Research output: Contribution to journal › Review Article › Research › peer-review
Press / Media
Experimental brain cancer drug cuts tumour growth in half and fuels hope for the future
16/05/19
1 item of Media coverage
Press/Media: Article/Feature
Experimental brain cancer drug cuts tumour growth in half and fuels hope for the future
16/05/19
1 item of Media coverage
Press/Media: Profile/Interview